Derivative exercise or conversion — not an open-market buy.
Traded Apr 10, 2026 · Filed Apr 15, 2026
Doximity's Interim PFO and PAO sold $51K of Doximity shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$51,185
Shares × reported transaction price
64 days after results of Feb 5, 2026, 33 days before results of May 13, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.5% | +1.6% | −0.1% |
| 30 days | −20.6% | +5.6% | −26.2% |
| 90 days | −8.8% | +7.4% | −16.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$60K of Doximity
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.